- Home
- NERV vs AIHS Comparison
NERV vs AIHS Comparison
Compare NERV & AIHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- AIHS
- Stock Information
- Founded
- NERV 2007
- AIHS 2014
- Country
- NERV United States
- AIHS China
- Employees
- NERV N/A
- AIHS N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- AIHS Finance: Consumer Services
- Sector
- NERV Health Care
- AIHS Finance
- Exchange
- NERV Nasdaq
- AIHS Nasdaq
- Market Cap
- NERV 10.3M
- AIHS 9.5M
- IPO Year
- NERV 2014
- AIHS 2018
- Fundamental
- Price
- NERV $1.78
- AIHS $0.91
- Analyst Decision
- NERV Hold
- AIHS
- Analyst Count
- NERV 1
- AIHS 0
- Target Price
- NERV $5.00
- AIHS N/A
- AVG Volume (30 Days)
- NERV 18.1K
- AIHS 15.1K
- Earning Date
- NERV 05-05-2025
- AIHS 02-14-2025
- Dividend Yield
- NERV N/A
- AIHS N/A
- EPS Growth
- NERV N/A
- AIHS N/A
- EPS
- NERV 0.19
- AIHS N/A
- Revenue
- NERV N/A
- AIHS $5,878,700.00
- Revenue This Year
- NERV N/A
- AIHS N/A
- Revenue Next Year
- NERV N/A
- AIHS N/A
- P/E Ratio
- NERV $9.00
- AIHS N/A
- Revenue Growth
- NERV N/A
- AIHS 12.21
- 52 Week Low
- NERV $1.15
- AIHS $0.77
- 52 Week High
- NERV $3.69
- AIHS $1.45
- Technical
- Relative Strength Index (RSI)
- NERV 59.64
- AIHS 54.48
- Support Level
- NERV $1.52
- AIHS $0.86
- Resistance Level
- NERV $1.81
- AIHS $0.91
- Average True Range (ATR)
- NERV 0.17
- AIHS 0.05
- MACD
- NERV 0.04
- AIHS -0.00
- Stochastic Oscillator
- NERV 95.45
- AIHS 65.83
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About AIHS Senmiao Technology Limited
Senmiao Technology Ltd is a holding company. The company's operating segment includes Automobile Transaction and Related Services focusing on the online ride-hailing industry in the People's Republic of China and Online ride-hailing platform Services through its own platform, Xixingtianxia. It generates maximum revenue from the Automobile Transaction and Related Services segment. Geographically, it derives revenue from China.